1033 GMT - The vaccine sector is under pressure after the nomination of Robert F. Kennedy Jr. as U.S.'s Health Secretary, but the market reaction looks overdone, Bryan Garnier Research analysts write. Kennedy is feared for his anti-vax positions, the analysts say. Shares in Pfizer, GSK, Moderna and BioNTech all dropped in Thursday's U.S. session and the sell-off has continued in Europe. Bavarian Nordic shares are down 16%, Valneva shares 6.1% lower with GSK and Sanofi both down 2.7%. However, the analysts believe the vaccine recommendation process has rigid structures in place, and U.S. governmental action will likely focus more on increased transparency and public information on vaccine risks and benefits. "We thus expect no impact on Valneva and Bavarian Nordic business near-term." (dominic.chopping@wsj.com)
(END) Dow Jones Newswires
November 15, 2024 05:34 ET (10:34 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。